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Résumé 
L’arthrite est l’une des causes principales de douleur et d’incapacité auprès de la 
population canadienne.  Les gens atteints d’arthrite rhumatoïde (AR) devraient être 
évalués par un rhumatologue moins de trois mois suivant l’apparition des premiers 
symptômes et ce afin de débuter un traitement médical approprié qui leur sera bénéfique.  
La physiothérapie et l’ergothérapie s’avèrent bénéfiques pour les patients atteints 
d’ostéoarthrite (OA) et d’AR, et aident à réduire l’incapacité.  Notre étude a pour but  
d’évaluer les délais d’attente afin d’obtenir un rendez-vous pour une consultation en 
rhumatologie et en réadaptation dans le système de santé public québécois, et d’explorer 
les facteurs associés. 
 Notre étude est de type observationnel et transversal et s’intéresse à la province de 
Québec. Un comité d’experts a élaboré trois scénarios pour les consultations en 
rhumatologie : AR présumée, AR possible, et OA présumée ; ainsi que deux scénarios 
pour les consultations en réadaptation : AR diagnostiquée, OA diagnostiquée. Les délais 
d’attente ont été mesurés entre le moment de la requête initiale et la date de rendez-vous 
fixée.  L’analyse statistique consiste en une analyse descriptive de même qu’une analyse 
déductive, à l’aide de régression logistique et de comparaison bivariée. 
 Parmi les 71 bureaux de rhumatologie contactés, et pour tous les scénarios 
combinés, 34% ont donné un rendez-vous en moins de trois mois, 32% avaient une attente 
de plus de trois mois et 34% ont refusé de fixer un rendez-vous.  La probabilité d’obtenir 
une évaluation en rhumatologie en moins de trois mois est 13 fois plus grande pour les cas 
d’AR présumée par rapport aux cas d’OA présumée (OR=13; 95% Cl [1.70;99.38]). 
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Cependant, 59% des cas d’AR présumés n’ont pas obtenu rendez-vous en moins de trois 
mois.  Cent centres offrant des services publics en réadaptation ont été contactés.  Pour 
tous les scénarios combinés, 13% des centres ont donné un rendez-vous en moins de 6 
mois, 13% entre 6 et 12 mois, 24% avaient une attente de plus de 12 mois et 22% ont 
refusé de fixer un rendez-vous.  Les autres 28% restant requéraient les détails d’une 
évaluation relative à l’état fonctionnel du patient avant de donner un rendez-vous. Par 
rapport aux services de réadaptation, il n’y avait aucune différence entre les délais 
d’attente pour les cas d’AR ou d’OA. 
L’AR est priorisée par rapport à l’OA lorsque vient le temps d’obtenir un rendez-
vous chez un rhumatologue.  Cependant, la majorité des gens atteints d’AR ne reçoivent 
pas les services de rhumatologie ou de réadaptation, soit physiothérapie ou ergothérapie, 
dans les délais prescrits. De meilleures méthodes de triage et davantage de ressources sont 
nécessaires. 
 
Mots-clés : Arthrite rhumatoïde, Ostéoarthrite, Délais d’attente, Rhumatologie, Soins 
spécialisés, Physiothérapie, Ergothérapie, Priorisation. 
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Abstract 
Arthritis is a leading cause of pain and disability in Canada. Persons with 
rheumatoid arthritis (RA) should be seen by a rheumatologist within three months of 
symptom onset to begin appropriate medical treatment and improve health outcomes. 
Early physical therapy (PT) and occupational therapy (OT) are beneficial for both 
osteoarthritis (OA) and RA and may prevent disability.  The objectives of the study are to 
describe wait times from referral by primary care provider to rheumatology and 
rehabilitation consultation in the public system of Quebec and to explore associated 
factors. 
 We conducted a cross-sectional study in the province of Quebec, Canada whereby 
we requested appointments from all rheumatology practices and public rehabilitation 
departments using case scenarios that were created by a group of experts.  Three scenarios 
were developed for the rheumatology referrals: Presumed RA; Possible RA; and Presumed 
OA and two scenarios for the rehabilitation referrals: diagnosed RA and diagnosed OA.  
Wait times were evaluated as the time between the initial request and the appointment date 
provided. The statistical analysis consisted primarily of descriptive statistics as well as 
inferential statistics (bivariate comparisons and logistic regression).   
 Seventy-one rheumatology practices were contacted.  For all scenarios combined, 
34% were given an appointment with a rheumatologist within three months of referral, 
32% waited longer than three months and 34% were refused services.  The odds of getting 
an appointment with a rheumatologist within three months was 13 times greater for the 
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Presumed RA scenario versus the Presumed OA scenario (OR=13; 95% Cl[1.70;99.38]).  
However, 59% of the Presumed RA cases did not receive an appointment within three 
months.  One hundred rehabilitation departments were also contacted.  For both scenarios 
combined, 13% were given an appointment within 6 months, 13% within 6 to 12 months, 
24% waited longer than 12 months and 22% were refused services. The remaining 28% 
were told that they would require an evaluation appointment based on functional 
assessment prior to being given an appointment. There was no difference with regards to 
diagnosis, RA versus OA, for the rehabilitation consultation. 
 RA is prioritized over OA when obtaining an appointment to a rheumatologist in 
Quebec.  However, the majority of persons with RA are still not receiving rheumatology 
or publicly accessible PT or OT intervention in a timely manner.  Better methods for 
triage and increased resource allocation are needed.   
 
Keywords: Rheumatoid Arthritis, Osteoarthritis, Wait Times, Rheumatology, Specialist 
Care, Physical Therapy, Occupational Therapy, Prioritization. 
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Chapter 1: Introduction 
In 2004, Canada’s First Ministers concluded A Ten-Year Plan to Strengthen Health 
Care, stating that improving access to care and reducing wait times were of national 
concern and a clear priority1.  Governments, health care professionals and Canadians have 
since struggled with the problem of wait times in several areas of the health care system 
and it has become increasingly relevant to report on provincial wait times in the public 
system in view of bringing change and improving wait times for Canadians.   
Arthritis is a leading causes of pain and disability in Canada and “despite the efforts 
to reduce the impact of arthritis on Canadians, it remains common, costly, and disabling” 
according to the Chief Public Health Officer2.  Arthritis includes more than a 100 
conditions that affect one or more joints as well as the tissues surrounding the joint, causing 
pain, swelling and stiffness3.   The two most common types of chronic arthritis are 
osteoarthritis (OA) and rheumatoid arthritis (RA)4.  A recent national report titled: “2010 
Life with Arthritis in Canada: A personal and public health challenge” provides an 
overview of the burden of arthritis on the Canadian population and underscores the 
importance and benefits of early intervention for persons with arthritis2.   
 Canadian Standards for Arthritis require that patients with suspected inflammatory 
arthritis, such as RA, obtain definitive diagnoses and treatment within four weeks of 
presentation to medical care5.  Generally, this requires rheumatology consultation6.  
Canadian rheumatologists report that once they are aware of an urgent referral, they will 
see that referral within two weeks or less7.  However, what happens in reality is unknown.  
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 Physical rehabilitation services, such as physical therapy (PT) and occupational 
therapy (OT), are beneficial for OA2, 8-10 as well as inflammatory arthritis such as RA2, 8-10. 
Effectiveness of PT and OT interventions has been demonstrated11-13, however, there are 
problems with access to these services14, 15. 
 Not much is known about wait times in the public system for chronic conditions, 
such as arthritis, in Quebec.  Despite this, significant literature has been built around the 
importance of early access to both specialist and rehabilitation care for persons with 
arthritis and specifically RA.        
 In this thesis, I will address the issues of wait times to rheumatology and 
rehabilitation services for persons with RA and OA in the public system of Quebec.  I will 
begin by presenting the available literature on the subject in Chapter 2 followed by the 
specific objectives and hypotheses of my study in Chapter 3.  Chapter 4 will consist of the 
methods used to carry out these objectives.  In Chapters 5 and 6, I will present two 
manuscripts, the first addressing the rheumatology component (access to specialist care) 
and the second addressing the rehabilitation component (access to PT and OT).  Chapter 7 
comprises a general discussion based on the results presented, the clinical implications and 
the direction of future research.  Lastly, a conclusion is found in Chapter 8.    
3 
 
Chapter 2: Literature Review 
2.1 Magnitude of the Problem  
Musculoskeletal diseases are the most common cause of severe long-term pain and 
physical disability and pose a considerable burden on both primary and secondary health 
care16, 17.  They are also the most costly group of diseases in Canada2 and consist of a broad 
range of disorders affecting the bones, muscles, ligaments and joints.   Arthritis accounts 
for almost one third of the total cost of musculoskeletal diseases in Canada and its greatest 
economical burden is attributed to long-term disability2.  People living with arthritis suffer 
from pain, impaired physical function and reduced quality of life, particularly with respect 
to their social, psychological and financial well-being.  More than 4.2 million Canadians 
live with some form of arthritis and the economical burden of this disease in 2000 was 
estimated to be $6.4 billion in direct (hospital care, drugs, physician billing, and additional 
health care expenditure) and indirect (lost productivity, injury, morbidity and mortality) 
costs2.  Arthritis is a serious economic and health burden to our society.   
 
2.2 Arthritis  
There are several types of arthritic conditions.  The two main types of arthritis are 
rheumatoid arthritis (RA) and osteoarthritis (OA).  In the next sections, I will describe these 
two conditions in terms of their disease presentation, epidemiology, diagnosis and 
treatment. 
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2.2.1 Rheumatoid Arthritis  
2.2.1.1 Disease Presentation and Epidemiology 
Rheumatoid arthritis is defined as a chronic, symmetric and destructive polyarthritis 
caused by systemic inflammatory and proliferative formation of synovial tissue that 
primarily affects one or more joints, but can also affect other organs18.  Although the exact 
cause is unknown, it is thought to be multifactorial and the result of an autoimmune 
response in a genetically susceptible individual.  The genetically predisposed individual 
exposed to environmental triggers (such as smoking) will be more likely to develop RA19, 
20.   
RA usually presents with painful swollen joints and morning stiffness21.  The 
inflammatory process causes painful swelling that can lead to the progressive destruction of 
ligaments, cartilage and bone3.  The pain and joint destruction inflicted by RA can 
significantly reduce functional capacity and cause joint instability, contractures and muscle 
atrophy.  The joints typically affected are the proximal inter-phalyngeals, meta-
carpophalyngeals, wrists, knees, ankles, meta-tarsophalyngeals and cervical spine.  It can 
also lead to nodule formation that affect the skin, tendons, heart or lungs and sometimes 
cause systemic illnesses such as vasculitis and predispose those affected to some forms of 
cancer (i.e lymphomas).   
The prevalence of RA in the developed world is between 0.5% and 1% of the 
population, affecting women twice as much as men, and the incidence is 32.7 new cases per 
100,0004.  There is a 50% increased risk of premature mortality for persons with RA and 
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life expectancy is decreased by three to ten years22.  The predominant conditions 
contributing to the comorbidity and mortality of RA are infections, renal impairment, 
lymphomas, and cardiovascular disease23.  
 
2.2.1.2 Diagnosis of Rheumatoid Arthritis 
 The 2010 diagnostic criteria for RA from the American College of Rheumatology 
and the European League Against Rheumatism states that definite RA is based upon the 
presence of synovitis in at least one joint, the absence of an alternative diagnosis better 
explaining the synovitis, and achievement of a total score of at least six (out of ten) from 
the individual scores in four domains24.  The highest score achieved in a given domain is 
used for this calculation.   
These domains and their values are as follows: 
1. Number and site of involved joints 
a. 2 to 10 large joints (from among shoulders, elbows, hips, knees, and ankles) 
= 1 point 
b. 1 to 3 small joints (from among the metacarpophalangeal joints, proximal 
interphalangeal joints, second through fifth metatarsophalangeal joints, 
thumb interphalangeal joints, and wrists) = 2 points 
c. 4 to 10 small joints = 3 points 
d. Greater than 10 joints (including at least one small joint) = 5 points  
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2. Serological abnormality (rheumatoid factor or anti-citrullinated peptide/protein 
antibody) 
a. Low positive (above the upper limit of normal (ULN)) = 2 points 
b. High positive (greater than 3 times the ULN) = 3 points 
3. Elevated acute phase response (erythrocyte sedimentation rate or C-reactive protein) 
(above the ULN = 1 point) 
4. Symptom duration (at least six weeks = 1 point) 
In addition to the criteria above, which are best suited to patients with newly presenting 
disease, the following persons are classified as having RA: 
• Persons with erosive disease typical of RA with a history compatible with prior 
fulfillment of the criteria above 
• Persons with longstanding disease, including those whose disease is inactive (with 
or without treatment) who have previously fulfilled the criteria above based upon 
retrospectively available data. 
 
2.2.1.3 Treatment of Rheumatoid Arthritis 
Possible treatments for RA include medication, exercise prescription, rehabilitation, 
counseling, maintaining a healthy weight, and self-management education2.   
There are five main types of drugs used to treat arthritis: analgesics, non-steroidal 
anti-inflammatory drugs (NSAIDs), corticosteroids, non-biologic disease-modifying anti-
rheumatic drugs (DMARDs) and biologic response modifiers2.  The pharmacological 
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treatment varies depending on the severity of RA.  Treatment of mild to moderate RA 
includes NSAIDs, DMARDs or a combination of both25. Severe cases of RA or milder 
cases that fail to respond to first line therapy are treated with potent biological agents25. 
Early, aggressive treatment initiated by a rheumatologist has been shown to prevent 
joint damage, slow progression of disease and increase quality of life26-28.  Treatment with 
DMARDs, which are a mainstay of therapy for RA29, work to suppress the body's 
overactive immune or inflammatory systems30 and should be used under the supervision of 
a rheumatologist31.  DMARDs interfere with various pathways in the inflammatory cascade 
by decreasing cellular proliferation, lessening auto-antibody response and reducing 
production of inflammatory molecules and have been shown to slow down progression of 
RA32. Milder forms of disease are treated by either antimalarial agents or sulfasalazine.  
The former includes agents such as chloroquine and hydroxychloroquine which are usually 
well tolerated but are prone to cause retinal toxicity which requires frequent 
ophthalmological examination33. Sulfasalazine, which has little systemic side effects, acts 
as a free radical scavenger that is thought to reduce inflammation and has been used 
successfully in both patients with inflammatory bowel disease and milder cases of RA.  
Moderate forms of RA are usually treated by a drug called methotrexate, a folate 
antimetabolite that inhibits DNA synthesis, either alone or in combination with the above34.  
Side effects include liver, bone marrow and fetal toxicity, and its effects should be assessed 
on a regular basis.  DMARDs take effect over weeks or months and are not designed to 
provide immediate relief of symptoms which is why they are often paired with the use of 
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corticosteroids and NSAIDs in the management of RA.  Ultimately, DMARDs work to 
decrease pain and inflammation, reduce or prevent joint damage, and preserve the structure 
and function of the joints30. 
Corticosteroid, such as prednisone, are potent agents that are used a bridge until 
DMARDs take their full effects, which can be well over 4 weeks35. Their use is limited by 
their extensive side effect profile associated with more chronic use.  Corticosteroids can 
cause skeletal fractures, gastrointestinal bleeding, diabetes mellitus, infections, cataracts 
and adrenal insufficiency.  
NSAIDs, such as ibuprofen or naproxen, work by reducing the production of 
inflammatory molecules, called prostaglandins, and primarily help to reduce pain. Common 
side effects include gastrointestinal irritation and bleeding, as well as renal failure and 
exacerbation of underlying ischemic heart disease36.   
More severe forms of RA require the addition of potent agents called biologics (or 
biological DMARDs) because there are derived from live organisms37. These agents 
include Anti Tumor Necrosis Factor (Etanercept, Infiximab), Anti Interleukin 1 (Anakinra), 
or Anti Lymphocyte (Rituximab). They work by antagonizing specific cells of the immune 
system or blocking the inflammatory cascade. They lead to a more pronounced suppression 
of the immune system and have been shown to reduce the progression of disease. Infections 
are frequent side effects and malignancies are not uncommon after prolonged use37. 
Non pharmacological treatment such as physical therapy (PT) and occupational 
therapy (OT) should also be considered when persons with RA are experiencing ongoing 
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inflammation or joint damage38.  PT and OT provide various services including education, 
exercise instruction, joint protection, assessment and prescription of assistive devices and 
introduction of self-management programs9, 12, 13, 39.  They use physical modalities such as 
the application of heat or cold and ultrasound, which are useful for persons with RA40-42.  
PT and OT can also significantly improve functional and work-related outcomes by using 
targeted and comprehensive patient assessments, educating patients about joint protection 
and self care, and providing assistive devices and splints43.  Exercise programs devised by a 
PT that include strength training, aerobics, and stretching have been shown to affect 
outcomes and increase quality of life44-47.  Stenstrom found that aerobic and dynamic 
exercises were best to prevent functional decline in persons with RA44.  Evidence supports 
the use of therapeutic exercise, especially knee functional strengthening, total-body 
functional strengthening, and general physical activity in the management of RA48.  
Particularly for RA, a low-intensity exercise program favors decreased pain and improved 
functional status as compared to a high-intensity program which may exacerbate the 
inflammatory process and risk damage to the affected joints48.  A systematic review of the 
literature found that OT improves the functional ability of persons with RA by decreasing 
pain and increasing grip strength49.  A Cochrane review conducted a few years later 
concluded similar results in that OT has a positive effect on functional ability by improving 
activities of daily living (ADLs) and decreasing pain in patients with RA50.  The strongest 
evidence was for the efficacy of instruction on joint protection technique50.  
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Maintaining a healthy weight and the participation in self-management education 
programs are other management strategies that help reduce the burden of disease2.  
Educating patients about the disease course and treatment options, teaching coping 
strategies to deal with pain and disability, and using cognitive-behavioural therapy and 
biofeedback have been shown to increase quality of life51. 
 
2.2.2 Osteoarthritis  
2.2.2.1 Disease Presentation and Epidemiology 
OA, sometimes referred to as degenerative joint disease, results from a gradual 
deterioration of articular cartilage and the thickening of the bone underneath caused from a 
wear-and-tear mechanism3.  This mechanism causes an alteration with the alignment, 
muscle strength, lubrication (provided by the synovial fluid) and the shock-absorbency 
(provided by the bone and cartilage) of the joint affected52.  Although it is considered a 
chronic and slowly progressing disease, it may present with suddenly worsening pain and 
swelling.  The vast majority of OA cases are thought to be idiopathic in nature.  Some cases 
result from systemic disease altering the bone structure but their incidence is small.  Risk 
factors for OA include advanced age, genetic predisposition, ethnicity, hormonal status, 
nutritional deficiencies, bone density, local biomechanical factors, and joint trauma3, 52.  
Local biomechanical factors include altered joint biomechanics, previous injuries, the 
effects of physical activity, sport participation, occupation, developmental abnormalities 
and obesity52.  
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It is estimated that 80% of the population aged over 65 years old has some evidence 
of OA.  However, it can also occur in younger persons.  Symptomatic knee OA affects an 
estimated 6% of persons aged 30 and over and 10-15% of adults aged over 60.  
Symptomatic hip OA occurs in 1-4% of adult and hand OA in 10-15%.  At least 33% of 
persons over 55 have radiographic evidence of OA, although the majority remain 
asymptomatic52.  Persons with OA were found to have excess mortality rates due to 
associated cardiovascular disease and dementia53, 54.   
   
2.2.2.2 Diagnosis of Osteoarthritis 
The diagnosis of OA is a gestalt of clinical, historical, and laboratory features.  OA 
does not affect all joints equally and has a predilection for the fingers, knees, hips, and 
spine, and rarely affects the elbow, wrist, and ankle52. Pain is the main symptom and is 
typically exacerbated by activity and relieved by rest. Inflammatory markers in blood and 
joint fluid are usually normal or minimally elevated 55-57.  Clinical and radiographic 
findings do not always correlate in the diagnosis of OA55.     
 
2.2.2.3 Treatment of Osteoarthritis 
Treatment strategies for OA include both pharmacological and non-pharmacological 
options58.  Pharmacological treatment consists of analgesics (such as acetaminophen), 
NSAIDs (such as ibuprofen or naproxen), as well as intra-articular corticosteroid injections, 
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which have all been shown to significantly decrease pain59, 60 and can be prescribed by a 
primary care provider or rheumatologist.  
Persons with OA are often managed by their primary care provider and referred to 
PT and OT for treatment.  Similarly to RA, PT and OT provide various services including 
education, exercise instruction, joint protection, assessment and prescription of assistive 
devices and introduction of self-management programs, which are beneficial8, 10, 11.  
Improving range of motion (ROM) and muscle strength through well designed exercise will 
decrease joint pain and increase mobility11. Modalities such as heat or cold and ultrasound 
have also proven useful for persons with OA61, 62.  PT and OT can also significantly 
improve functional and work-related outcomes by using targeted and comprehensive 
patient assessments, educating patients about joint protection and self care, and providing 
assistive devices and splints43.  
Weight loss and the maintenance of a healthy weight through dieting and exercise 
have also been shown to have potential benefits63. Participation in self-management 
education programs can lead to significant improvements in pain and functional scores64. 
Educating patients about the disease course and treatment options, teaching coping 
strategies to deal with pain and disability, and using cognitive-behavioural therapy and 
biofeedback have been shown to increase quality of life51. 
Persons with OA who fail to respond to conventional treatment or suffer from 
ongoing pain despite pharmacological and non-pharmacological therapy are candidates for 
surgical interventions10, 65.  It has been shown that joint replacement of the hip or knee 
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reduces pain and improves functional status for at least five years in the majority of 
patients66.  Other surgical options such as arthroscopic lavage and debridement are less 
invasive but do not necessarily alter disease progression of OA67.  Cost-effectiveness 
analyses have shown joint replacement to be cost-saving or cost-equivalent (compared to 
nonoperative management) especially if there is a greater functional limitation pre-
operatively68.  Effective nonoperative treatment of OA includes rehabilitation, activity 
modification, weight loss, adaptive equipment, analgesics, interarticular injections, etc.11.  
 
2.3 Benefits of Early Management 
 Persons with inflammatory arthritis, such as RA, should be seen by healthcare 
professionals early to begin appropriate treatment and improve health outcomes5.  
According to the standards for Arthritis Prevention and Care issued by the Alliance for the 
Canadian Arthritis Program (ACAP), patients with suspected inflammatory arthritis should 
obtain definitive diagnoses and appropriate treatment within four weeks of presentation to a 
healthcare professional5. Generally, this requires consultation with a rheumatologist6 as 
they are adept at diagnosing and managing inflammatory arthritic conditions and well-
versed in the current standards for pharmacologic treatment.  
A significant body of literature suggests delayed initiation of treatment may have 
detrimental effects on disease activity, functional capacity, radiographic changes, and the 
induction of remission69-72.  Therefore, patients with inflammatory arthritis should be seen 
by a specialist within three months of diagnosis to begin early and aggressive medical 
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treatment with DMARDs in order to slow or even prevent the process of joint destruction 
and disability73-78.  Quality of care and health outcomes are better for RA patients who have 
contact with a rheumatologist compared to those who do not72, 79.  This contact should be 
established as early as possible because once patients are seen by rheumatologists, there 
tends to be little delay to diagnosis and treatment77. 
There are no clear-cut recommendations for early access to rheumatology for 
persons with OA.  The literature suggests that OA can be managed by a primary care 
provider, however the British Columbia Guidelines for OA indicates that a referral to 
rheumatology may also be useful to diagnose unusual presentations of OA and optimize 
pharmacological treatment80.  One study showed that the tendency to refer persons with 
osteoarthritis to rheumatology was greater than orthopedics (approximately 17-24% to 
orthopedics versus 44-56% to rheumatology)81.  Persons with OA may only be referred to 
an orthopedic surgeon in severe cases, which likely require surgical intervention as 
mentioned in section 2.2.2.3.  Regardless of the type of care provider, early treatments and 
lifestyle changes such as maintaining a healthy body weight and avoiding joint stress may 
help reduce or even prevent the burden of OA2.   
Besides access to a rheumatologist, persons with arthritis (RA and OA) may benefit 
from physical rehabilitation services such as PT and OT.  The main goals of PT and OT 
intervention are to decrease pain, prevent deformity, preserve or improve function, and 
promote participation in ADLs as well as both vocational and leisure activities2, 8-10, 12, 62, 82.  
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Early intervention, such as educational programs and splinting, with PT or OT may help 
improve the quality of life of person with arthritis83, 84.   
 
2.4 Components of Wait Times 
The care trajectories for persons with arthritis are composed of several stages which 
can each contribute to the wait times to rheumatology and rehabilitation consultation.  The 
successful delivery of these services would begin with a person’s recognition of symptoms 
and presentation to a primary care provider.  The primary care provider would then conduct 
appropriate investigations and refer to a rheumatologist if arthritis, particularly RA, is 
suspected.  The rheumatologist would then provide a diagnosis and begin appropriate 
pharmacological treatment as well as non-pharmacological treatment, which may include 
referral to rehabilitation services, community resources or orthopaedic surgery (if it was not 
already done by the primary care provider). There are many opportunities for delays within 
this trajectory:  the wait time from symptom onset to initial consultation with a primary 
care provider, the wait time from primary care provider consultation until referral to 
rheumatology and/or rehabilitation services and finally, our focus, the wait time from 
referral by primary care provider until rheumatology and rehabilitation consultation.  
In terms of rehabilitation services (PT and OT) persons with arthritis may access 
public (insured under the public provincial health insurance program – the Régie 
d’assurance maladie du Québec) rehabilitation services through referral from their 
physician (family physician or specialist) or private services (whereby the patient is 
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required to pay themselves, or may have supplementary insurance coverage).  In the case of 
private services, PT and OT can be accessed directly without a referral.   
 
2.5 Referral to Rheumatology Services  
RA is the most common inflammatory arthropathy that primary care providers 
encounter.  The vast majority (91%) of Canadian rheumatologists surveyed say that, once 
aware of an urgent RA referral, they will see the referred patient within two weeks or less7.  
Nevertheless, evidence in Canada shows that early consultation with a rheumatologist 
remains problematic85, 86.   
Several studies have evaluated the wait time from symptom onset to initial 
consultation with a primary care provider, as well as the wait time from initial consultation 
until the commencement of appropriate DMARD treatment (which usually occurs under the 
care of a rheumatologist)73, 74, 87.  A recent retrospective cohort study in the Greater Toronto 
Area concluded that less than a quarter (23%) of patients referred to rheumatologists were 
treated within three months of symptom onset and the mean time from symptom onset to 
initiation of DMARDs was 6.4 months77.  Similarly, a national multi-centered study 
revealed that only 18.1% are treated with DMARDs within the three-month “window of 
opportunity”87.  This study also concluded that the major component of the lag-time to 
obtain appropriate treatment occurs prior to rheumatology referral (78%): primary care 
delays to rheumatology referral account for 51% of the total lag-time and the remaining 
27% may be due to delays in seeing a primary care practitioner12.  In Quebec, one must be 
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referred by a primary care provider in order to see a rheumatologist.  According to one 
study, wait times between the referral by the primary care provider and the rheumatology 
consultation account for only 14% of the total lag-time to begin appropriate treatment12.    
A study of Quebec administrative data suggested that only 27% of persons with 
newly suspected RA consulted with a rheumatologist and for those who did consult, time to 
consultation was lengthy88.  However, this study was based on physician billing data; 
quality control of diagnostic coding and absence of severity indicators therefore limit the 
conclusions.  The issue was pursued further, by exploring time of consultation with a 
rheumatologist for patients with a confirmed diagnosis of inflammatory arthritis, as well as 
factors associated with rapidity of consultation89.  The investigation was conducted on 
patients recruited to an early inflammatory arthritis registry in Quebec.    Even within the 
context of an “early” arthritis registry, the mean time from symptom onset to rheumatology 
consultation was 4.4 months and 59.9% of patients consulted rheumatologists past the three 
month recommended window89.  In a study conducted in the United Kingdom, 53.4% of 
patients with inflammatory arthritis were seen by a rheumatologist within six weeks of 
referral by the family physician, 31.1% were seen between six and 12 weeks and 15.5% 
waited longer than 12 weeks90.  The “rate limiting steps” appear to be the time from 
symptom onset to primary care consultation, and time from primary care consultation to 
referral by the primary care provider to the rheumatologist91.  Nevertheless, there is still 
some improvement that can be made with respect to the wait from referral to rheumatology 
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and consultation with the rheumatologist.  Furthermore, this may be one component that 
may be more easily amenable to improvement.   
The manpower shortage of Canadian rheumatologists18 as well as factors related to 
the physician, the clinical setting, and regional location (i.e. urban vs. rural), likely 
influence wait time to a rheumatologist and then the referral behaviour of a physician4.  
Over-reliance on the results of laboratory tests, such as rheumatoid factor, may result in 
sub-optimal use of referrals5,6.  There is also evidence that demographics are important as 
elderly patients with RA may have decreased access to care7 and there may also be bias 
related to patient-sex, although there is conflicting evidence as to the direction of the latter 
8,9.   Moreover, a study evaluating the variations in referral rates of general practitioners to 
specialists found that general practitioners were influenced by patient-associated factors, 
provider associated factors and case-specific factors (i.e. type of condition or office)92.   
 
2.6 Referral to Rehabilitation Services   
Effectiveness of PT and OT interventions has been demonstrated for both RA and 
OA11-13, however, there are problems with access to such services14, 15.  This is especially 
problematic in view of the increasing prevalence of chronic arthritis as well as the 
economic burden associated with these disabling diseases2. 
Although not documenting actual wait times to receive services, Beatty et al. 
reported that among the 32.2% of patients with arthritis (RA or OA) who felt that they 
needed rehabilitation services (including PT, OT and assistive devices), only 58.3% 
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actually received these services14.   Another study reported similar results: among 39% of 
patients with arthritis (RA or OA) who felt they needed rehabilitation services, including 
PT and OT, only 61% received it15.   
A physician survey in Quebec demonstrated that general practitioners do not tend to 
refer persons with RA for PT or OT, but are more likely to do so for persons with OA93.  
The percentage of rheumatologists who referred patients with RA for these services was 
almost 3 times higher than general practitioners.  Physicians who worked in geographic 
areas that offer rehabilitation services were more likely to refer93.  Though there is little 
research on the subject, low referral of patients to rehabilitation may be driven by a lack of 
understanding of the role of PT and OT90, especially with regards to RA.   
Patient-related factors may also be associated with use of PT and OT.  For example, 
RA patients with lower socioeconomic status (SES) received less allied health care 
(including PT and OT) than patients with higher SES23.  Severity and longer duration of the 
condition as well as insurance status and ability to pay for services were associated with 
referral to PT for patients with spine disorders24.    
In Quebec, PT and OT are only covered by the public provincial health insurance 
plan for services received in hospitals, rehabilitation centres, and community health 
centres94 (which offer care to homebound persons for the most part and favour persons who 
have been discharged recently from hospital care or post-operative patients).  Most PTs and 
some OTs work in private clinics95 where patients either pay for the services themselves, or 
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have supplemental insurance (often by their employer) that cover a certain number of 
therapy sessions.   
PT and OT play an important role in the prevention and management of symptoms 
associated with OA and RA and their intervention can potentially keep persons independent 
longer by promoting activity and participation through their wide variety of treatments96-98.  
With more persons requiring arthritis care, the demands on PT and OT will undoubtedly 
increase for this population.  Further, the availability of publicly insured (by the provincial 
health insurance board) PT and OT services has decreased in Canada over the past two 
decades, presenting barriers to access especially for those who do not have supplementary 
health insurance99. 
 
2.7 Prioritization 
In light of the importance of early diagnosis and treatment of RA, the demand for 
rheumatology consultation has increased making it even more important to develop 
strategies to assure that appointments are obtained in a standard and prompt fashion.  An 
arthritis cohort study in New Zealand indicated that the only factor predicting earlier 
treatment for RA was triage allocation based on the requested urgency of the referring 
physician100.  De Coster et al. conducted a literature review as part of a larger project to 
develop a rheumatology priority referral.  However, no single priority-setting criterion was 
identified for rheumatic disorders101.  Although there is not very much literature on the 
topic, De Coster et al. as well as two other studies concluded that a structured referral tool 
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to prioritize referrals is a critical component of improving access to care and the referral 
process to rheumatology for persons with RA100-102.   
A central access and triage system for specialized medical services was created and 
implemented in the province of Alberta81.  This study showed a decreased in the mean wait 
times for: urgent cases went from 29 to 17 days; moderately urgent cases 110 to 63 days; 
and non-urgent cases from 155 to 108 days81.  The McGill University Health Centre 
(MUHC) in Montreal Quebec, is currently using a rheumatology triage tool in the context 
of a pilot study103.  This pilot study suggests that a standardized rheumatology referral form 
may increase awareness of RA among family physicians and result in quicker 
rheumatology referral and less dependency on laboratory findings103.   
In the United Kingdom (UK), nurse practitioners (NP) and rehabilitation therapists 
triage rheumatology referrals using standardized guidelines to help reduce the burden on 
the rheumatologists104, 105. The NP, working independently or in conjunction with a 
rheumatologist, performs musculoskeletal examinations, monitors progress and offers 
recommendations with regards to medication. When this service was combined with that of 
a rheumatologist in the UK, patients reported less pain, better knowledge and greater 
patient satisfaction104, 106.  
It has also been reported that specially trained PTs in the UK screen and assess 
orthopaedic referrals which helps to reduce the referrals to the orthopaedics104, 107.   This 
screening model reduced referrals to orthopaedic departments by 17% and to rheumatology 
departments by 8%.  Appropriate referral increased from 50% to 90% within two years of 
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implementation of this model105. The Hospital for Sick Children in Toronto, Canada, has a 
similar system with trained PT and OT practitioners who conduct clinics and provide 
treatments within and beyond their tradition roles108.  The parent and patient satisfaction in 
PT practitioner-led clinics was equally as high as physician-led clinics109.  
Literature is emerging on the topic of rheumatology triage and prioritization in 
Canada and there is evidence of referral tools being piloted and rehabilitation-led programs 
to help decrease wait times and reduce the caseload burden of rheumatologists. 
2.8 Summary 
Arthritis is a serious economic and health concern for Canadians.  RA is a common 
chronic disease that should be treated early with DMARDs in order to prevent serious 
disability and deformity.  Early rheumatology consultation for patients with RA is a key 
part of optimal clinical care, since these specialists are experts in using DMARDs, which 
prevent joint destruction.  Despite this, current evidence shows that early consultation with 
a rheumatologist in the public system is problematic.  Although there is no evidence that 
persons with OA benefit from early drug treatment, there are benefits with respect to 
exercise, weight loss, adapted equipment, intra-articular injections and self management 
programs and beginning these sooner may be beneficial to optimize outcomes.   
PT and OT are beneficial for persons with arthritis (RA and OA) and play an 
important role in the prevention and management of symptoms and their intervention can 
potentially keep persons independent longer by promoting activity and participation 
through their wide variety of treatments.  There appears to be a lack of publicly accessible 
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rehabilitation services and community resources for persons with arthritis.  The literature 
suggests that there are problems with regards to accessibility to these services in the public 
system of Quebec but they have not yet been formally identified.    
The care trajectory for persons with arthritis is composed of several stages which 
can each contribute to the wait time to consultation with a rheumatologist.  These include 
the wait time from symptom onset to initial consultation with a primary care provider, the 
wait time from primary care provider consultation until referral to rheumatology and 
finally, our focus, the wait time from referral by primary care provider until rheumatology 
consultation.   Current literature pertaining to rheumatology and rehabilitation referrals in 
Quebec is based primarily on self-report, surveys and administrative data.  The majority of 
these studies look at time from symptoms onset to referral or time from seeing a family 
physician until referral to specialist care.  However, little is known regarding the reality of 
wait time from referral to initial consultation with a rheumatologist and rehabilitation 
services in Quebec.  This study addresses this particular gap. 
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Chapter 3: Objectives and Hypothesis 
3.1 Objectives 
The main goal of this study is to determine the time to obtain an appointment to 
rheumatology and rehabilitation services for persons with arthritis, namely RA or OA. 
The specific objectives are as follows: 
1) To describe wait times from referral by primary care provider to rheumatology 
consultation in the public system Quebec; 
2) To describe wait times from referral by primary care provider to physical or 
occupational therapy consultation in the public system of Quebec;  
3) To explore whether these wait times are associated with referral scenario (i.e. 
diagnosis), type of office or geographic area.  
 
3.2 Hypotheses 
The hypotheses of this study were:  
1) The wait time to receive an appointment with a rheumatologist will be on 
average less than three months.   
2) The wait times to receive an appointment to physical or occupational therapy 
will be on average less than six months.   
3) Persons with RA will be offered appointments to rheumatology sooner than 
those with OA.  The wait for physical or occupational therapy will be very 
similar for persons with RA and OA.   
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Chapter 4: Methods 
 
The following section describes the methods used for this study. First, the process of 
obtaining approval from the ethics committee is described.   Then, the procedure is 
explained in two components: 1) Rheumatology Component and 2) Rehabilitation 
Component. 
 
4.1 Ethics Approval 
 Ethics approval was obtained from the Université de Montreal and McGill University 
(Appendix A). Both organizations judged that this study did not require a full review from 
the ethics board as it does not involve subjects and is a quality assurance study.   
 
4.2 Study Design 
This was a cross-sectional study. 
 
4.3 Procedure 
This study took place in the province of Quebec, Canada, where healthcare is 
delivered through a publicly funded system. The following section describes how the data 
were collected for both components of this study.   
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4.3.1 Rheumatology Component Procedure 
In order to determine the wait time from the referral by a physician to rheumatology 
consultation, we first developed referral scenarios to be used in order to procure an 
appointment.  These scenarios were elaborated by a focus group consisting of two 
rheumatologists and two family physicians.  The consensus was to create referral scenarios 
based on a 55 year old female which were as realistic as possible and resembled cases that 
they would have seen in clinical practice.  Three cases were developed: a classical 
presentation of RA (Presumed RA), a complex presentation of RA (Possible RA), and a 
classical presentation of OA (Presumed OA).  This would allow us to compare the two 
different presentations of RA as well as RA versus OA.  
The three referral scenarios were: 
 1) Presumed RA: “55 year old female with bilateral swollen and tender wrists and 
MCPs. Morning stiffness of 1 hour.  ESR: 22, CRP: 30, RF: 68.  Please rule out 
RA”; 
2) Possible RA: “55 year old female with 3 month history of severe pain and 
swelling of hands and feet.  Unable to work secondary to pain.  NSAIDS not 
helping. Possible RA. Please assess and treat”; and  
3) Presumed OA: “55 year old female with pain right knee x 10 yrs, no swelling.  X-
Ray: early OA? Please assess”.   
The scenarios were used to request appointments for rheumatology consultation in 
all publicly accessible (non-private) rheumatology offices in the province of Quebec. 
Referral scenarios were translated into both French and English: English referrals to serve 
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the McGill network and French to serve the Université de Montréal, Université de 
Sherbrooke and Université Laval networks.  Wait times were calculated as the time 
between the initial request and the appointment date given.  All appointments obtained 
were subsequently cancelled within 24 hours.       
All rheumatology offices in Quebec were contacted, including solo and group 
practices as well as hospital based departments.  Two research assistants contacted 71 
rheumatology offices between July 2009 and July 2010, to request an appointment based on 
the referral scenarios and follow up if required.  There are two potential ways that a 
referring physician can arrange a specialty visit in Quebec: either the referring doctor’s 
office calls or sends a referral letter by fax or by post; or the referring doctor may give the 
referral letter to the patient and ask him or her to call the specialist to arrange the 
appointment (with the understanding that the patient will bring the referral sheet on the day 
of the appointment).  Research assistants initially called each office, assuming the role of a 
patient with one of the prepared referral scenarios. The three different scenarios were used 
in random order over a period of months, for each office.  A standardized script was 
employed to request the appointment while also obtaining information about the 
appointment booking method and type of office (academic versus non-academic).  If the 
research assistant was told that no appointment would be given before receipt of the 
referral, faxed referrals were sent to the offices that required them, and subsequently 
followed up by a phone call to schedule the appointment.  However, in some cases the 
rheumatology office requested information that could not be provided (valid health 
insurance number, local address and local telephone numbers).  In these cases and in other 
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situations when an appointment date was not given over the telephone (i.e. if the 
receptionist said that the “patient” would be called back with an appointment date), the 
research assistant would inquire as to the estimated wait time and note the method for the 
provision of appointments.  
 
4.3.2. Rehabilitation Component Procedure 
In order to determine the wait time from the referral by a physician to PT or OT 
consultation, two referral scenarios were developed.  A focus group of two PTs, two OTs, 
two rheumatologists and two family physicians was formed in order to create referral 
scenarios based on a 55 year old female which were as realistic as Possible and resembled 
cases that they would have seen in their own practices.  Generally, to obtain an appointment 
with PT or OT in the public system the patient requires a diagnosis made by the physician; 
therefore different scenarios were created for the rehabilitation component. 
The two referral scenarios consisted of: 
1) Diagnosed RA: “55 year old female with RA suffering from severe pain and 
swelling of hands and feet.  Morning stiffness of 1 hour.  ESR: 22, CRP: 30, RF: 
68.  Please assess.”  
and  
2) Diagnosed OA: “55 year old female with OA suffering from chronic pain in right 
knee x 5 years, no swelling.  Please assess”.   
The scenarios were used to request appointments for PT and OT consultation in all 
publicly accessible (non-private) PT and OT hospital-based departments, community health 
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centres, and rehabilitation centres in Quebec.  Referral scenarios were translated into both 
French and English: English referrals to serve the McGill network and French to serve the 
Université de Montréal, Université de Sherbrooke and Université Laval networks.  Wait 
times were calculated as the time between the initial request and the appointment date 
given.   
Two research assistants contacted all the publicly accessible service providers 
between April 2010 and June 2010, to request an appointment based on the referral 
scenarios and follow up if required.  For both components there are two potential ways that 
a referring physician can arrange a rehabilitation consultation in Quebec: either the 
referring doctor’s office calls or sends a referral letter by fax or by post; or the referring 
doctor may give the referral letter to the patient and ask him or her to call to arrange the 
appointment (with the understanding that the patient will bring the referral sheet on the day 
of the appointment).  For this component, the research assistant called each service 
provider, assuming the role of a patient with one of the prepared referral scenarios.  The 
two different scenarios were used in random order over a period of three months.  A 
standardized script was employed to request the appointment while also obtaining 
information about the type of service provider (hospital, community health centre or 
rehabilitation centre).  In the event that certain information could not be provided (valid 
health insurance number, local address and local telephone numbers) or in some cases when 
an appointment date was not given over the telephone (i.e. if the receptionist said that the 
“patient” would be called back with an appointment date or the referral was needed prior to 
booking an appointment), the research assistant would inquire as to the estimated wait time 
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as well as the method for the provision of appointments.  If an appointment was obtained, it 
was subsequently cancelled 24 hours later. 
 
4.4 Analysis 
 The following section describes the statistical analysis used for both components of 
the study. 
 
4.4.1. Rheumatology Component 
Analysis of data consisted of descriptive statistics as well as bivariate analysis to 
assess whether the wait times (≤3 months, or > 3 months) were associated with the booking 
method (telephone or fax), type of office (academic versus non-academic offices) or 
geographic region (Montreal versus the rest of the province of Quebec). A generous three 
month cut-off was used as a benchmark to reflect the current Canadian recommendations73-
76.  Conditional logistic regression was used to evaluate whether the wait time from referral 
to consultation was associated with type of diagnosis (RA or OA) to account for the 
matched nature of the design (each clinic was asked to provide appointments for both OA 
and RA cases).   
Since early treatment is recommended for persons with RA, factors associated with 
early appointments for RA were assessed using bivariate analysis and multivariate logistic 
regression.  In the logistic regression model, we sought to determine whether wait time (≤3 
months, or > 3 months) from referral to consultation with a rheumatologist for persons with 
RA was associated with type of office (academic versus non-academic offices) or 
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geographic region (Montreal versus the rest of the province of Quebec).  These variables 
were included to test whether academic offices may be more attuned to the urgency of RA 
referrals, and whether existing regional differences in terms of per-capita availability of 
rheumatologists may affect wait times to see a rheumatologist. 
 
4.4.2. Rehabilitation Component 
 Descriptive statistics were used to examine the wait times in relation to the 
diagnosis, service provider (hospital, community health centre or rehabilitation centre) and 
geographic area (cities with a School of Rehabilitation versus the rest of the province of 
Quebec).  The administrative regions containing a School of Rehabilitation with both PT 
and OT included Montreal, Estrie (Sherbrooke) and Capitale-Nationale (Quebec City).   
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WAIT TIMES FOR RHEUMATOLOGY CONSULTATION: 
IS RHEUMATOID ARTHRITIS PRIORITIZED? 
Delaurier, A.; Bernatsky,S.; Baron, M.; Légaré, J.; Ehrmann Feldman, D. 
 
ABSTRACT 
 
Objectives: Persons with RA should be seen by healthcare professionals within three 
months of symptom onset to begin appropriate treatment and improve health outcomes.  
The objectives of the study are to describe wait times from referral by primary care 
provider to rheumatology consultation and to explore associated factors.   
 
Methods: Our cross-sectional study took place in the province of Quebec, Canada.  
Appointments were requested by telephone using case scenarios that were created by a 
group of experts.  Three scenarios were developed for rheumatology referral: 1) Presumed 
RA; 2) Possible RA; and 3) Presumed osteoarthritis (OA).   Wait times were evaluated as 
the time between the initial request and the appointment date provided. The statistical 
analysis consisted of descriptive statistics, bivariate analysis, and logistic regression. 
 
Results: For all scenarios combined, 34% were given an appointment with a 
rheumatologist within three months of referral, 32% waited longer than three months and 
34% were told that the rheumatologist was not accepting new referrals at the time the 
request was made.  The logistic regression revealed that the odds of getting an appointment 
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with a rheumatologist within three months of referral by the primary care provider was 13 
times greater  for the Presumed RA scenario versus the Presumed OA scenario (OR=13; 
95% Cl[1.70;99.38]).   
 
Conclusions: Our study suggests that RA is prioritized over OA when obtaining an 
appointment to a rheumatologist in the province of Quebec.  However, the majority of 
persons with RA are still not receiving an appointment to a rheumatologist in a timely 
manner.   
 
ABBREVIATED ABSTRACT:  Persons with RA should be seen by a physician within 
three months of symptom onset to begin appropriate treatment and improve health 
outcomes.  Rheumatologists are experts in the management of this condition.  The aim is to 
describe wait times from referral by primary care provider to consultation with a 
rheumatologist.  Appointments were requested in the province of Quebec using case 
scenarios and wait times were defined as the time between initial request and appointment 
date.  RA is prioritized over OA, however, the majority of persons with RA are still not 
receiving an appointment to a rheumatologist in a timely manner.   
 
KEY WORDS: Rheumatoid Arthritis, Wait Times, Prioritization, Specialist Care 
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INTRODUCTION: 
Arthritis, one of the most prevalent chronic health conditions, is the leading cause of 
pain and disability in Canada2 and contributes greatly to the utilization of healthcare 
services.  Two major types of arthritis are inflammatory (i.e. rheumatoid arthritis (RA)) and 
non-inflammatory arthritis (i.e. osteoarthritis (OA)).  Persons with inflammatory arthritis 
should be seen by healthcare professionals early to begin appropriate treatment and 
improve health outcomes5.  According to the standards for Arthritis Prevention and Care 
issued by the Alliance for the Canadian Arthritis Program (ACAP), patients with suspected 
inflammatory arthritis should obtain definitive diagnoses and appropriate treatment within 
four weeks of presentation to a healthcare professional5. Generally, this requires 
consultation with a rheumatologist6.  There are no recommendations with respect to 
consultation with a rheumatologist for persons with non-inflammatory arthritis.  Persons 
with OA are often managed by their primary care provider and current treatments include 
pain medication, exercise, physical and occupational therapies, weight loss or healthy 
weight management and, in severe cases, joint replacement surgery2. 
A significant amount of literature suggests that patients with inflammatory arthritis 
be seen by a specialist within three months of diagnosis to begin early and aggressive 
medical treatment with disease-modifying anti-rheumatic drugs (DMARDs) in order to 
slow or even prevent the process of joint destruction and disability73-76.  Quality of care and 
health outcomes are better for RA patients who have contact with a rheumatologist 
compared to those who do not79.  The vast majority (91%) of Canadian rheumatologists 
surveyed say that, once aware of an urgent RA referral, they will see the referred patient 
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within two weeks or less7.  Nevertheless, current evidence in Canada shows that early 
consultation with a rheumatologist remains problematic85, 86.   
The care trajectory for persons with RA is composed of several stages which can 
each contribute to the wait time to consultation with a rheumatologist.  These include the 
wait time from symptom onset to initial consultation with a primary care provider, the wait 
time from primary care provider consultation until referral to rheumatology and finally, our 
focus, the wait time from referral by primary care provider until rheumatology consultation.  
Little is known regarding the time from referral to initial consultation to a rheumatologist.  
The main goal of our study was to address this gap, i.e. to describe wait times from referral 
by the primary care provider to rheumatology consultation and to further explore whether 
wait times are associated with type of arthritis diagnosis, geographic area or type of office.   
 
METHODOLOGY 
Our cross-sectional study took place in the province of Quebec, Canada, where 
healthcare is delivered through a publicly-funded healthcare system.  In order to determine 
the wait time from the referral by a primary care provider to rheumatology consultation, 
three referral scenarios were developed with the input of two rheumatologists and two 
family physicians.  The referral scenarios, based on a 55 year old female, were created to be 
as realistic as possible and consisted of: 1) Presumed RA: “55 year old female with 
bilateral swollen and tender wrists and MCPs. Morning stiffness of 1 hour.  ESR: 22, CRP: 
30, RF: 68.  Please rule out RA”; 2) Possible RA: “55 year old female with 3 month history 
of severe pain and swelling of hands and feet.  Unable to work secondary to pain.  NSAIDS 
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not helping. Possible RA. Please assess and treat”; and 3) Presumed osteoarthritis (OA): 
“55 year old female with pain right knee x 10 yrs, no swelling.  X-Ray: early OA? Please 
assess”.  The scenarios were used to request appointments for rheumatology consultation in 
all publicly accessible (non-private) rheumatology offices in Quebec.  Wait times were 
calculated as the time between the initial request and the appointment date given.  All 
appointments obtained were subsequently cancelled within 24 hours.       
We approached all of the rheumatology offices in Quebec, including solo and group 
practices as well as hospital based departments.  Two research assistants contacted 71 
rheumatology offices between July 2009 and July 2010, to request an appointment based on 
the referral scenarios.  There are two potential ways that a referring physician can arrange a 
specialty visit in Quebec: either the referring doctor’s office calls or sends a referral letter 
by fax or by post; or the referring doctor may give the referral letter to the patient and ask 
him or her to call the specialist to arrange the appointment (with the understanding that the 
patient will bring the referral sheet on the day of the appointment).  For our study, research 
assistants initially called each office, assuming the role of a patient with one of the prepared 
referral scenarios. The three different scenarios were used in random order over a period of 
months, for each office.  A standardized script was employed to request the appointment 
while also obtaining information about the appointment booking method and type of office 
(academic versus non-academic).  If the research assistant was told that no appointment 
would be given before receipt of the referral, we sent faxed referrals to the offices that 
required them, and then called the office again (Figure 1).  However in some cases the 
rheumatology office requested information that we could not provide (valid health 
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insurance number, local address and local telephone numbers).  In these cases and in other 
situations when an appointment date was not given over the telephone (i.e. if the 
receptionist said that the “patient” would be called back with an appointment date), the 
research assistant would inquire as to the estimated wait time as well as the method for the 
provision of appointments.  
Analysis of data consisted of descriptive statistics as well as bivariate analysis to 
assess whether the wait times (≤3 months, or > 3 months) were associated with the booking 
method (telephone or fax), type of office (academic versus non-academic offices) or region 
(Montreal versus the rest of the province of Quebec). A three month cut-off was used as a 
benchmark to reflect the current Canadian recommendations73-76.  We used conditional 
logistic regression to evaluate whether wait time from referral to consultation was 
associated with type of diagnosis (RA or OA) to account for the matched nature of the 
design (each clinic was asked to provide appointments for both OA and RA cases). Since 
early treatment is recommended for persons with RA, we also assessed factors associated 
with early appointments using bivariate analysis and multivariate logistic regression.  In the 
logistic regression model, we sought to determine whether wait time (≤3 months, or > 3 
months) from referral to consultation with a rheumatologist for persons with RA was 
associated with type of office or region. These variables were included to test whether 
academic offices may be more attuned to the urgency of RA referrals, and whether existing 
regional differences in terms of per-capita availability of rheumatologists may affect wait 
times. 
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RESULTS 
Of the 71 rheumatology offices contacted, 24 of the offices were hospital settings: 
12 were academic hospitals and 12 were community hospitals. The remaining 47 offices 
consisted of 37 solo practices and 10 group practices.  The administrative region of 
Montreal accounted for 55% of the rheumatology offices in the province.  In the case of a 
single booking office for multiple rheumatologists (i.e. hospital or group practice) only one 
call was made for each scenario, regardless of the number of physicians. 
For all scenarios combined, 34% were given an appointment with a rheumatologist 
within three months of referral, 32% waited longer than three months and in an additional 
34% of cases, the patient was told that the rheumatologist was not accepting new patients at 
the time the request was made (Figure 2).  Regarding the percent of patients who received 
an appointment within three months, the results were very similar between the Presumed 
RA (41%, 95% CI[0.29,0.53]) and the Possible RA cases (38%, 95% CI[0.27,0.49]).  
However, a lower percentage of patients with Presumed OA (24%, 95% CI[0.14,0.34]) 
received an appointment within three months.  When looking at appointments for both RA 
or OA, the odds of an appointment with a rheumatologist within three months of referral 
from the primary care provider were almost three times greater for the Montreal region 
compared to the rest of the province (OR=2.91; CI[1.34,6.32]).  Booking method 
(telephone or fax) and type of office (academic versus non-academic) were not associated 
with getting an appointment within three months.  
Using conditional logistic regression, the odds of getting an appointment with a 
rheumatologist within three months of referral by the primary care provider was 13 times 
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greater for the Presumed RA scenario versus the Presumed OA scenario (OR=13; 95% 
Cl[1.70;99.38]).   
Twenty three of the 71 offices (32%) were not accepting new patients at the time the 
request was made; the majority of these (66%) were non-academic solo or group practices. 
Of the 48 offices accepting new patients, 58% provided appointments by telephone and 
42% required a faxed referral.  Among those accepting new patients, there were no 
differences between phone and fax referrals for RA cases obtaining an appointment within 
3 months (60.7% for phone versus 60% for fax referrals, p=0.96).  There was a tendency 
for more patients receiving an appointment within 3 months at the academic centres (50%, 
95% CI [0.38,0.62] ) versus other offices (39%  95% CI [0.28,0.50] ), although there is 
overlap of the confidence intervals. 
Looking solely at the Presumed RA scenario, bivariate analysis indicated that the 
percentage of patients who obtained an appointment to a rheumatologist within three 
months was higher among patients living in the Montreal region (49%, 95% CI[0.37,0.61])  
as opposed to the rest of the province (31%,95% CI[0.20,0.42]), although the confidence 
intervals for the estimates overlapped.   
The logistic regression model (Table 1) revealed that the odds of an appointment 
with a rheumatologist within three months of referral from the primary care provider for 
Presumed RA were more than three-fold greater for the Montreal region compared to the 
rest of the province and more than four-fold greater for appointments obtained by calling 
after the required referral was faxed to the office.  The type of office (academic versus non-
academic) was not associated with getting an appointment within three months. 
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DISCUSSION 
Improving access to health services and decreasing wait times is a priority for many 
governments, including Canada.  Our data emphasize that persons with new-onset RA in 
Quebec may not always receive prompt rheumatology care.   Even though our study 
assessed only the wait time to see a rheumatologist post-referral by primary care provider, 
the wait time for the RA cases was greater than three-months in almost two thirds of the 
rheumatology offices assessed.  This is problematic since current recommendations state 
that patients with new-onset RA should receive rheumatology care (diagnosis and 
DMARDs) within three months of symptom onset in order to optimize their outcome73-76.   
Several studies have evaluated the wait time from symptom onset to initial 
consultation with a primary care provider, as well as the wait time from initial consultation 
until the commencement of appropriate DMARD treatment (which usually occurs under the 
care of a rheumatologist)73, 74, 87.  A national multi-centered study revealed that only 18.1% 
are treated with DMARDs within the three-month “window of opportunity”87. A study of 
Quebec administrative data suggested that only 27% of persons with newly suspected RA 
consulted with a rheumatologist, and for those who did consult, time to consultation was 
lengthy88. Even within the context of an early inflammatory arthritis registry, more than half 
the patients consulted rheumatologists past the three months recommended window89. In a 
study conducted in the United Kingdom, 53.4% of patients with inflammatory arthritis 
were seen by a rheumatologist within six weeks of referral by the family physician, 31.1% 
were seen between six and 12 weeks and 15.5% waited longer than 12 weeks90.  The “rate 
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limiting steps” appear to be the time from symptom onset to primary care consultation, and 
time from primary care consultation to referral by the primary care provider to the 
rheumatologist91.  However, our study indicates that there are problems even after the 
referral is made.   
Possible reasons for wait times include inadequate or non-existent triage.  There was 
great variability seen within the different rheumatology offices with regards to their 
booking method.  Despite that, our study suggests that Presumed RA scenarios were 
prioritized over Presumed OA scenarios.  This is consistent with a retrospective study at the 
McGill University Health Centre which showed that even without a formal triage system 
persons with inflammatory arthritis may end up with a shorter wait time for reasons that 
remain unclear110.  This could be indicative of some sort of prioritization (formal or 
informal) whereby the office appropriately assigns earlier appointments for urgent 
inflammatory conditions (new onset RA) versus non-urgent and non-inflammatory cases 
(OA).  It also appeared that the receptionist plays a role in the prioritization of patients, 
particularly for the appointments obtained by telephone.    
A limitation of our study was the inability to provide the personal details required 
by some offices, which could have expedited the initial consultation with a rheumatologist 
and provided us with more accurate wait times for each scenario.  As previously mentioned, 
in those cases, we were still able to obtain an estimated wait time for the appointment date 
from the receptionist verbally.  However, we do not know how valid that estimate was. As 
well, we were unable to account for the additional time that might have been required to 
organize the information requested, resend the referral, and receive a response from the 
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rheumatology office.  Moreover, had the primary care provider spoken directly to the 
rheumatologist to discuss the case or had the patient called the office again offering to take 
the place of a cancellation, it could have also affected the wait times.  Nonetheless, our data 
suggest that more than half of the offices do not use any formal triage for new patients.  
There was also the inability to account for staffing issues (i.e. a department being short-
staffed for any reason including vacation, sick leave, etc.), which could have contributed to 
the wait times.   
The wait times as well as the large number of rheumatology offices not accepting 
new referrals could be explained by the manpower and resource shortage of Canadian 
rheumatologists111.  The number and types of referrals, patient loads, and scheduling 
constraints may also present some challenges with respect to seeing patients in a timely 
fashion.  Factors related to the type of office and regional location (urban versus rural), 
likely influence the referral behaviour of a physician112.  This could explain the trend seen 
for the difference between Montreal and other regions of the province.  In terms of 
availability of rheumatology services, 55% of the rheumatology centres in Quebec were 
located in the administrative region of Montreal (population of greater Montreal area is 
approximately 3.8 million) and only 10% in the Capitale-Nationale region (population of 
the greater Quebec City area is approximately 746,300).   
Our study focused solely on one component of the wait time (from referral until 
consultation with the rheumatologist) and does not address the other components.  
According to one Canadian study, the wait time between the referral by the primary care 
provider and the rheumatology consultation accounts for only 14% of the total lag-time to 
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begin appropriate treatment87.  However, our study suggests that almost 60% of persons 
with new onset RA are not being seen by rheumatologists within three months post-referral, 
which means that their total wait time is much longer than current standards.  Moreover, 
even among those Presumed RA scenarios who did receive an appointment within three 
months, there is still the time to referral to consider.  This is extremely problematic.  
Nevertheless the wait time to see a rheumatologist may be the most amenable to 
improvement since rheumatologists strongly advocate for the need to see persons with RA 
as soon as possible (and according to a Canadian survey, try to see such patients within 2 
weeks)7.  A possible strategy to decrease the wait time may be the establishment of a 
standardized model of triage or guidelines to ensure that referrals are completed and 
appointments are obtained in a prompt fashion.  This is being piloted in more than one 
centre in Quebec103.  Increasing patient and family physician awareness regarding the 
importance of early access to rheumatology care is vital for persons with RA.   
 
CONCLUSION 
Our study suggests that RA is somewhat prioritized over OA when obtaining an 
appointment to a rheumatologist in the province of Quebec.  However, the majority of 
persons with RA are still not receiving an appointment to a rheumatologist in a timely 
manner.  Better methods for triage and increased resource allocation are needed.   
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Figure 1: Flow Chart to Obtain an Appointment with a Rheumatologist in Quebec 
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Figure 2: Rheumatology Wait Times in Quebec 
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TABLE 1: Factors Associated with an Appointment to a Rheumatologist within Three Months of 
Referral for Presumed RA Cases 
 
Factor OR 95% CI 
Type of Office (Academic vs non) 0.93 0.24; 3.68 
Region (Montreal vs other) 3.39 1.07;10.76 
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WAIT TIMES FOR PHYSICAL AND OCCUPATIONAL THERAPY IN THE 
PUBLIC SYSTEM FOR PERSONS WITH ARTHRITIS IN QUEBEC 
Delaurier A., Bernatsky S., Raymond M.-H., Ehrmann Feldman D. 
 
ABSTRACT 
 
Purpose: Arthritis is the leading cause of pain and disability in Canada. Physical therapy 
(PT) and occupational therapy (OT) are beneficial for chronic osteoarthritis (OA) as well as 
inflammatory arthritis such as rheumatoid arthritis (RA), however there appears to be 
problems with access to such services.  The aim of this study was to document the wait 
times from referral by physician to consultation in PT or OT in the public system of 
Quebec for persons with arthritis.  
 
Method: Appointments were requested by telephone using case scenarios and wait times 
were defined as the time between initial request and appointment date. Descriptive statistics 
were used to examine the wait times in relation to the diagnosis, service provider and 
geographic area. 
 
Results: For both scenarios (OA and RA) combined, 13% were given an appointment 
within 6 months, 13% within 6 to 12 months, 24% waited longer than 12 months and 22% 
were refused services. The remaining 28% were told that they would require an evaluation 
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appointment based on functional assessment prior to being given an appointment. There 
was no difference with regards to diagnosis, RA versus OA.  
Conclusions: Our study suggests that most persons with arthritis living in the province of 
Quebec are not receiving publicly accessible PT or OT intervention in a timely manner.   
 
KEY WORDS: Physical Therapy, Occupation Therapy, Wait Times, Arthritis 
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INTRODUCTION 
Physical rehabilitation services such as physical and occupational therapy are 
beneficial for chronic osteoarthritis (OA)2, 8-10 as well as inflammatory arthritis such as 
rheumatoid arthritis (RA)2, 8-10. Persons with OA are often managed by their primary care 
provider with pain medication and referred to physical therapy (PT) and occupational 
therapy (OT)2.  The recommendations for RA include pharmacologic management under 
the supervision of a rheumatologist; referral to PT and OT should be considered for patients 
who have ongoing inflammation or joint damage38.  Physical and occupational therapists 
provide various services (including education, exercise instruction, joint protection, 
assessment and prescription of assistive devices, introduction of self management 
programs, etc.) that are beneficial to persons with arthritis8-10. The main goals of PT and OT 
intervention are to decrease pain, prevent deformity, preserve or improve function, and 
promote participation in activities of daily living (ADLs) as well as both vocational and 
leisure activities12, 62, 82. Effectiveness of PT and OT interventions has been demonstrated11-
13, however, there are problems with access to such services14, 15.  This is especially 
problematic in view of the increasing prevalence of chronic arthritis as well as the 
economical burden associated with these disabling diseases2. 
In Quebec, medical care is delivered by a publicly funded healthcare system.  
However, PT and OT are only covered by the provincial health insurance plan for services 
received in hospitals, rehabilitation centres, and community health centres (which offer care 
to homebound persons for the most part and favour persons who have been discharged 
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recently from hospital care or post-operative patients).  Most PTs and some OTs work in 
private clinics95 where patients either pay for the services themselves, or have supplemental 
insurance (often by their employer) that covers a certain number of therapy sessions.   
PT and OT play an important role in the prevention and management of symptoms 
associated with OA and RA and their intervention can potentially keep persons independent 
longer by promoting activity and participation through their wide variety of treatments96, 97.  
With more persons requiring arthritis care, the demands on PT and OT will undoubtedly 
increase for this population.  Further, the availability of publicly insured (by the provincial 
universal health insurance board) PT and OT services has decreased in Canada over the 
past two decades, presenting barriers to access especially for those who do not have 
supplementary health insurance99. 
The main goal of our study was to document the wait times from referral by 
physician to consultation in PT or OT in the public system for persons with arthritis and to 
explore whether these wait times differed depending on the type of diagnosis (RA versus 
OA), service provider (hospital, community health centre or rehabilitation centre) and 
geographic area (cities with a School of Rehabilitation versus the rest of the province).  We 
also described any methods of prioritization used for the provision of appointments.     
   
METHODS 
Our cross-sectional study took place in the province of Quebec, Canada.  In order to 
determine the wait time from the referral by a physician to PT or OT consultation, two 
referral scenarios were developed with the input of two PTs, two OTs, two rheumatologists 
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and two family physicians.  The referral scenarios, based on a 55 year old female, were 
created to be as realistic as possible and consisted of: 1) Diagnosed RA: “55 year old 
female with RA suffering from severe pain and swelling of hands and feet.  Morning 
stiffness of 1 hour.  ESR: 22, CRP: 30, RF: 68.  Please assess.” and 2) Diagnosed OA: “55 
year old female with OA suffering from chronic pain in right knee x 5 years, no swelling.  
Please assess”.  The scenarios were used to request appointments for PT and OT 
consultation in all publicly accessible (non-private) PT and OT hospital-based departments, 
community health centres, and rehabilitation centres in Quebec.  Wait times were 
calculated as the time between the initial request and the appointment date given.   
A single research assistant contacted all the publicly accessible service providers 
between April 2010 and June 2010, to request an appointment based on the referral 
scenarios.  There are two potential ways that a referring physician can arrange a 
rehabilitation consultation in Quebec: either the referring doctor’s office calls or sends a 
referral letter by fax or by post; or the referring doctor may give the referral letter to the 
patient and ask him or her to call to arrange the appointment (with the understanding that 
the patient will bring the referral sheet on the day of the appointment).  For our study, the 
research assistant called each service provider, assuming the role of a patient with one of 
the prepared referral scenarios.  The two different scenarios were used in random order 
over a period of three months.  A standardized script was employed to request the 
appointment while also obtaining information about the type of service provider (hospital, 
community health centre or rehabilitation centre).  In the event that we could not provide 
certain information (valid health insurance number, local address and local telephone 
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numbers) or in some cases when an appointment date was not given over the telephone (i.e. 
if the receptionist said that the “patient” would be called back with an appointment date or 
the referral was needed prior to booking an appointment), the research assistant would 
inquire as to the estimated wait time as well as the method for the provision of 
appointments.  If an appointment was obtained, it was subsequently cancelled 24 hours 
later. 
Descriptive statistics were used to examine the wait times in relation to the 
diagnosis, service provider (hospital, community health centre or rehabilitation centre) and 
geographic area (cities with a School of Rehabilitation versus the rest of the province of 
Quebec).  The administrative regions containing a School of Rehabilitation with both PT 
and OT included Montreal, Estrie (Sherbrooke) and Capitale-National (Quebec).   
 
RESULTS 
There are 100 public PT and OT service providers serving the adult outpatient 
population of Quebec.  Among these, 12% are hospital teaching centres, 74% are 
community health centres (i.e. community hospitals or Health and Social Service 
Centres,(CSSS)) and 14% are rehabilitation centres for persons with physical impairments 
and disabilities.  Approximately one-fifth (21%) of the service providers are located in the 
administrative region of Montreal, the largest city in the province and home of two Schools 
of Rehabilitation (McGill University and Université de Montréal).  
For both scenarios (OA and RA) combined, 13% were given an appointment within 
6 months, 13% within 6 to 12 months, 24% waited longer than 12 months and 22% were 
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refused services (Figure 3).  The remaining 28% were told that they would require an 
evaluation appointment based on a functional assessment prior to being given an 
appointment.  Reasons for refusals included service providers only accepting patients 
referred internally by their institution (36%), only accepting post-operative or trauma 
patients (27%), not accepting persons with a diagnosis of RA or OA (18%), not accepting 
new patients at the time the request was made (10%) and finally, only accepting patients 65 
years old and older (9%).  Upon refusal or when a long wait time was given, the 
receptionist would often suggest that the patient seek private PT and OT services.  
There was no difference with regards to diagnosis, RA versus OA, for patients 
obtaining an appointment by telephone.  However, 28% of the service providers offered the 
patient an evaluation appointment, which implies some type of screening or prioritization 
based on their functional assessment as opposed to their diagnosis.  The wait time would 
therefore be dependant on the need of the patient and prioritized accordingly at each service 
provider’s discretion.  When looking at the provision of an evaluation appointment prior to 
beginning services, a statistically significant difference (p=0.006) was found between cities 
with a School of Rehabilitation (10%, 95% CI 0.09,0.11) and the rest of the province (36%, 
95% CI 0.32,0.40). The majority of the evaluation appointments were in the community 
health centres (82%) compared to the other service providers (p=0.07).  Additionally, 70 of 
the 100 service providers required that the referral be sent for their review before the initial 
consultation regardless of the evaluation appointment.    
Looking solely at the 50 service providers who gave an indication of the wait time, 
26% were given an appointment within six months, 26% were given an appointment within 
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six to 12 months and 48% were told that they would have to wait longer than 12 months.  
The diagnosis (RA versus OA) and service provider (hospital versus community health 
centre versus rehabilitation centre) was not associated with getting an earlier appointment 
(Table 2).  However, none of the rehabilitation centres provided an appointment within six 
months for the RA or OA case scenarios compared to 13 of the 86 other PT and OT 
departments (15%) who provided an appointment within six months.   
 
DISCUSSION 
Improving access to health services and decreasing wait times is a priority for many 
governments, including Canada.  We found problems with access to public PT and OT 
services for persons with arthritis (RA and OA) in terms of long wait times and 
unavailability of services for this population in over a fifth of the cases.  Although not 
documenting actual wait times to receive services, Beatty et al. reported that among the 
32.2% of patients with arthritis who felt that they needed rehabilitative services (including 
PT, OT, and assistive devices), only 58.3% actually received these services14.  Hagglund et 
al. reported similar results: among 39% of patients who felt they needed rehabilitative 
therapies (PT and OT) only 61% received it15.  Feldman et al. conducted interviews directly 
with patients and found that 96% of patients who felt they needed rehabilitation services 
received these services, however only 26.1% of patients perceived the need for these 
services93.  Our study was based on hypothetical scenarios of patients: these patients were 
presumably referred to PT and OT because of the physician’s assessment of need.  Yet, 
only 26% were given an appointment within a year of referral. 
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Our findings echo the results of a qualitative study in Quebec that assessed 
therapists’ perceptions regarding barriers and facilitators of access to PT and OT for 
persons with RA.   Therapists pointed out that access to publicly-available programs was 
very limited99 forcing patients to either pay for private services, or go without these 
services.  This underscores the effect of socioeconomic status as a factor influencing access 
to PT and OT.  In fact, the therapists believed that in many cases, a physician would not 
even initiate a referral because they were well-aware that their patient would be unable to 
gain access to a therapist99.   Persons with higher levels of education are also more likely to 
perceive the need for therapy services93, 113-116, possibly indicating better knowledge about 
potential benefits.   
Sandhu et al. suggested that low referral to rehabilitation may be driven by a lack of 
understanding of the roles of PT and OT90.  Based on the reasons for refusal to give an 
appointment, our data suggests that service providers or their administration perceive a 
greater PT and OT need for patients with acute conditions (i.e. post-operative conditions, 
traumas, fractures, or recent hospital admissions) or the elderly.  This is consistent with 
Passalent et al. in that arthritis is categorized as a chronic condition and is therefore less 
prioritized in rehabilitation services95.  Therefore, developing patient, physician and 
therapist awareness regarding the importance and benefits of early access to PT and OT 
care is extremely important. Campaigns like the widespread efforts to improve joint 
replacement outcomes (which is a priority area in Quebec, as in the rest of Canada) could 
actually potentially drain resources from other patient groups in need (such as those with 
chronic arthritis). 
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The excessive wait times for rehabilitation services reflect a need for re-evaluation 
of the supply and demand as well as the role of therapists as leaders in prevention and 
education for patients with rheumatic conditions.  Adequate organization of publicly and 
privately accessible services is even more crucial given that staff shortages in OT117 and PT 
118 have been identified.  Although there did not appear to be a formal triage system in place 
in all centres, more than a quarter of the public rehabilitation service providers gave 
evaluation appointments to new patients.   The majority of these were in the community 
health centre setting, possibly indicating the need for prioritization in this setting since there 
are increasing demands for PT and OT in community settings.  These evaluation 
appointments serve as a form of triage, to determine the needs of each patient as well as 
serving as an opportunity for therapists to provide some basic education to the patients 
regarding their condition.   
  We found no difference between RA and OA when requesting an appointment by 
phone.  Moreover, no associations were found between obtaining an earlier appointment 
and the type of service providers.   
Arthritis is the leading cause of pain and physical disability in Canada and has 
become a major public health challenge and economic burden2.  PT and OT interventions 
can optimize function and increase participation.  A focus is needed on developing 
strategies so that the referrals are completed and appointments are obtained rapidly and 
easily.  Potential strategies include the development of a standardized model of 
prioritization or guidelines to ensure the provision of appointment in a timely manner.  
Moreover, knowing that persons with arthritis are not always receiving prompt 
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rehabilitation services, the implementation of management strategies to decrease the impact 
of arthritis through education, awareness and self management programs2 could be 
provided by rehabilitation professionals.  The evaluation of service delivery is also 
extremely important as therapist shortages could be further accentuated by the organization 
of these services118.        
 
LIMITATIONS 
A limitation of our study was the inability to provide the personal details required 
by some departments, which could have expedited the initial consultation process and 
provided us with more accurate wait times for each scenario.  As previously mentioned, in 
those cases, we were still able to obtain an estimated wait time for the appointment date 
from the receptionist verbally.  However, we do not know how valid that estimate was or 
how an evaluation appointment would have affected the wait times.  Additionally, our 
study does not account for the wait time differences between PT and OT as wait times were 
calculated as the time between the initial request and the appointment date received by one 
of the rehabilitation professionals, i.e. PT or OT.  Although the OA case falls more likely 
under the scope of practice of PTs and the RA case under the scope of practice of OTs, 
these patients could have benefited from the expertise of both professionals.  There was 
also the inability to account for staffing issues (i.e. a department being short-staffed for any 
reason including vacation, sick leave, etc.), which could have contributed to the wait times.   
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CONCLUSION 
 Our study suggests that most persons with arthritis living in the province of Quebec 
are not receiving publicly accessible PT or OT intervention in a timely manner.  Improved 
methods for triage and better resource allocation are needed to optimize function and 
participation for these persons.   
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Figure 3: 
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Table 2: Factors Associated with Obtaining an Appoitment to Physical and Occupation 
Therapy  within six months 
 
  < 6 months  
n (%) 
> 6 months 
n (%) 
P-Values 
RA 13 (26%) 37 (74%) 
Diagnosis 
OA 13 (26%) 37 (74%) 
p=1 
Hospital 2 (29%) 5 (71%) 
Community Health Centre 11 (28%) 28 (72%) 
Type of 
Centre 
Rehabilitation 0 (0%) 4 (100%) 
p=0.46 
Academic Cities 4 (27%) 11 (73%) 
Region 
Rest of the province 9 (26%) 26 (74%) 
p=0.94 
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Chapter 7: Discussion 
In this section, the results of this research study will be summarized and further 
discussed. The clinical implications, limitations and direction of future research will also be 
explored.   
 
7.1 Summary of Results and Key Points 
The main objective of this study was to determine the time to obtain an appointment 
to rheumatology and rehabilitation services for persons with arthritis, namely RA or OA.  
The results pertaining to these objectives are summarized below as well as key discussion 
points from the manuscripts.   
  
7.1.1 Rheumatology Component 
7.1.1.1 Summary of Results 
We found that among 71 rheumatology service providers in Quebec and irrespective 
of referral diagnosis (RA or OA) 34% were given an appointment with a rheumatologist 
within three months of referral, 32% waited longer than three months and 34% were told 
that the rheumatologist was not accepting new referrals at the time the request was made 
(Figure 2).  Persons with RA were 13 times more likely to get an appointment with the 
rheumatologist within 3 months of referral than those with OA.  However, 59% of the  RA 
cases did not receive an appointment within three months.   
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7.1.1.2 Summary of Key Points 
The results from the rheumatology component emphasize that persons with new-
onset RA in Quebec are not always receiving prompt rheumatology care.  This study 
focused solely on one component of the wait time (from referral until consultation with the 
rheumatologist) which is thought to be only 14% of the total wait-time to begin appropriate 
treatment87.  However, our study suggests that almost 60% of persons with new onset RA 
are still not being seen by rheumatologists within three months post-referral, which means 
that their total wait time is much longer than current standards.  These wait times are 
unacceptable as present recommendations state that patients with new-onset RA should 
receive rheumatology care (diagnosis and DMARDs) within three months of symptom 
onset in order to optimize their outcome73-76.  Moreover, there is a substantial body of 
literature built up around the importance of early aggressive treatment initiation by a 
rheumatologist to prevent joint damage, slow progression of disease and improve quality of 
life26-28.      
 
7.1.2 Rehabilitation Component 
7.1.2.1 Summary of Results 
Among the 100 public rehabilitation service providers in Quebec, 13% of patients 
with either RA or OA were given an appointment within 6 months, 13% within 6 to 12 
months, 24% waited longer than 12 months and 22% were refused services (Figure 3).  The 
remaining 28% were told that they would require an evaluation appointment based on 
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functional assessment prior to being given an appointment. There was no difference with 
regards to diagnosis, RA versus OA, for the rehabilitation consultation. 
  
7.1.2.2 Summary of Key Points 
There are problems with access to public PT and OT services for persons with RA 
and OA, specifically in terms of long wait times.  Over one fifth of the patients were 
refused services and only 13% were given an initial appointment within 6 months which 
suggests that persons seeking timely access to PT or OT would have to pay for private 
services.  Previous research in Quebec indicated that therapists believed that often 
physicians do not refer because they suspect that their patient would be unable to gain 
access to a therapist99.   
 
7.2 Comparison of Rheumatology and Rehabilitation Components  
Both the rheumatology and rehabilitation components of this study were based on 
hypothetical scenarios of patients.  These patients were presumably referred to 
rheumatology and rehabilitation services because of the physician’s assessment of need, yet 
referrals resulted in unacceptably long wait times to initial consultation and in many cases 
patients were even refused services at that particular clinic or department. 
The long rheumatology wait times as well as the large number of rheumatology 
offices not accepting new referrals could be explained by the manpower and resource 
shortage of Canadian rheumatologists111.   Similarly, staff shortages in OT117 and PT 118 
have been identified which could have contributed to the long wait times for rehabilitation 
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services.  Adequate organization of publicly accessible services and resource allocation is 
even more crucial given the increasing prevalence of arthritis2 and the manpower shortages 
already identified.   
In the case of rheumatology accessibility it is clear that this has to be a priority 
based on evidence.  For rehabilitation services, the research may be less compelling, but it 
is reasonable to believe that early treatment will decrease deformity and prevent disability.  
Improving and maintaining function is extremely important also for the wellbeing of the 
individual.  It would appear that the Canadian medical model still tends to be reactive rather 
than proactive. In the past, often persons with the most severe disease were those who were 
prioritized for treatment.  The paradigm may need to be shifted: instead of focusing on only 
high risk patients it is important to address the needs of average risk persons who can 
potentially develop serious complications and problems.  This obviously requires some 
reorganization in resources and development and implementation of novel service delivery 
options within a system that is already overstretched financially.  One strategy may be 
improved ways to prioritize patients for prompt management.  This will be discussed in the 
next section. 
 
7.3 Prioritization 
7.3.1 Rheumatology Component 
We found that there was great variability within the different rheumatology offices 
with regards to their booking methods and no consistent prioritization method or tool was 
used throughout the centres.  Despite that, RA scenarios were prioritized over OA scenarios 
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for rheumatology consultation.  This is consistent with a retrospective study at the McGill 
University Health Centre, which showed that even without a formal triage system persons 
with inflammatory arthritis might end up with a shorter wait time for reasons that remain 
unclear110.  This could be indicative of some sort of prioritization (formal or informal) 
whereby the office appropriately assigns earlier appointments for urgent inflammatory 
conditions (new onset RA) versus non-urgent and non-inflammatory cases (OA).  It is also 
possible that the receptionist plays a role in the prioritization of patients, particularly for the 
appointments obtained by telephone.  If that is the case, efficiency of prioritization may 
depend on the capability of the receptionist to discern whether a referral is in fact a 
probable inflammatory arthritis patient or not. 
There is an increase in literature on the topic of rheumatology prioritization and 
potential prioritization tool100-102, 119.  De Coster et al. demonstrated that there is currently 
no reliable and valid measurement tool that rates the urgency for referrals from primary 
care providers to rheumatologists101.  An arthritis cohort study in New Zealand indicated 
that the only factor predicting earlier treatment for RA was triage allocation based on the 
requested urgency of the referring physician100.  Another study aimed to formulate and test 
a “Priority Referral Score” suggested that the referrals requiring expedited consultation 
should be referred directly to the rheumatologist (i.e. by telephone) and should not be 
placed on the wait list119.   There is a consensus that a structured and reliable referral tool to 
prioritize referrals is a critical component of improving access to care and the referral 
process to rheumatology for persons with RA100-102.   
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A Canadian study, which took place in Alberta, developed a central access and 
triage system for specialized medical services (which included rheumatology) and 
implemented it within the province81.  There was a decrease in patient visits in both primary 
care and specialty care because all the information and required tests were provided within 
the central access and triage system81.  This resulted in improved accessibility, decreased 
wait times and enhanced coordination of care for Albertans81.  Another study evaluated the 
use of electronic consultation request process, called “eReferrals”, as a method to reduce 
wait times92.  This system facilitated communication between primary care providers and 
specialty care and showed numerous improvements among which were decreased wait 
times and fewer inappropriate referrals to specialty care92. 
A Norwegian study monitored the prioritization of services based on established 
national medical guidelines to insure the allocation of funds and the quality assurance of 
priority settings in public health-care system120.  The diseases with the highest priority were 
those with guidelines stating that they should be seen for consultation within four weeks 
and low priority diseases were considered those that could wait six months or longer for 
consultation.  The authors state that even though the global efforts to reduce the average 
wait time was achieved, there was more of an impact on low priority diseases as their wait 
times were more reduced than the wait time for the highest priority diseases.  A possible 
reason for these results was that the system did not encourage the reduction of wait time 
specifically for high priority diseases and it was easier to have an impact by reducing the 
long wait times of those with low priority disease120. 
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Rheumatology referral triage may have the potential to increase the timeliness with 
which more urgent cases are seen.  However, how best to implement these tools is still 
undetermined.  It could be hypothesized that provision of resources or sources of 
motivation (such as financial incentives120) would likely increase the chances of successful 
uptake of the referral triage among rheumatologist in Quebec.   
 
7.3.1 Rehabilitation Component 
There was no prioritization noted between the RA and OA cases for the 
rehabilitation service providers and, similarly to the rheumatology component, there did not 
appear to be a formal triage system which was consistent across the centres.  However, 
more than a quarter of the public rehabilitation service providers gave evaluation 
appointments to new patients which implies some type of prioritization based on 
assessment.   The evaluation appointments serve as a form of triage, to determine the needs 
of each patient and present an opportunity for therapists to, presumably, provide some basic 
education to the patients regarding their condition.  Moreover, this initial contact with 
either PT, OT or an interdisciplinary rehabilitation team may serve as an opportunity to 
teach self-management strategies, joint protection techniques and home exercise programs 
which are effective treatments for both RA and OA2.  The majority of the centres offering 
the evaluation appointment were community health centres, possibly indicating a greater 
need for prioritization in this setting that serves all of the community needs for PT and OT.   
 The development of a prioritization tool may be useful in rehabilitation services.  A 
study conducted in the Baffin Region of Nunavut, Canada, which developed a tool to 
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prioritize PT referrals found improved equity for PT service delivery and better job 
satisfaction among the PTs following the implementation of this tool121.  However, a study 
evaluating a centralized model of triage for prioritization for community rehabilitation 
services showed that only moderate agreement (30% disagreement of triage decisions) 
when deciding on the patient priority for PT and OT83.  It is possible that a standardized 
tool with increased objective criteria would enhance the agreement.      
Based on the reasons for refusal to give an appointment, it would appear that 
rehabilitation service providers or their administration perceive a greater PT and OT need 
for patients with acute conditions (i.e. post-operative conditions, traumas, fractures, or 
recent hospital admissions) or the elderly.  This is consistent with Passalent et al. in that 
arthritis is categorized as a chronic condition and is therefore less prioritized in 
rehabilitation services95, 122.  Thus, developing patient, physician and therapist awareness 
regarding the importance and benefits of early access to PT and OT care is extremely 
important.  However, awareness is only the first step.  Concrete measures to improve access 
to care are sorely needed.  One such measure is expanding the role of the rehabilitation 
professional.  Expanding awareness and expanded roles of rehabilitation professionals will 
be discussed in the next sections. 
 
7.4 Role of the Rehabilitation Professional  
 
PT and OT interventions can optimize function and increase participation2, 96-98.  
Rehabilitation professionals, particularly PT and OT, can play a role in education, health 
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promotion, disease prevention, condition assessment, treatment and management of patients 
with arthritis.   
Raising patient and family physician awareness regarding the importance of early 
access to rheumatology and rehabilitation care is vital for persons with arthritis.  An 
increased understanding of the roles of PT and OT90 and their benefits could help increase 
referrals rates to rehabilitation services by primary care providers.  Patient education about 
potential advantages of PT and OT could facilitate greater perceived need and encourage 
patients to seek services93, 113-116.  PTs and OTs have the expertise to communicate this 
knowledge to physicians and patients and to work as leaders in prevention, health 
promotion and public health.  
The excessive wait times for rheumatology and rehabilitation services reflect a need 
for re-evaluation of the supply and demand in arthritis care.  Rehabilitation professionals 
may help fill the current care gap as they develop and expand their roles as advanced-
practice health care professionals108, 123.  PTs and OTs have an extensive knowledge of the 
musculoskeletal system and an array of clinical skills which facilitate their role as 
advanced-practice clinicians.  The advanced-practice PT in outpatient orthopaedic clinics 
has been present in the Ontario system for several years now and has been shown to 
decrease wait times for patients awaiting orthopaedic surgery124.  They can also offer 
conservative management options for those who do not require surgery and enhance the 
management of those who do124.  There is evidence that specially trained PTs in the UK 
screen and assess orthopaedic referrals which helps to reduce inappropriate referral to the 
orthopaedics department104, 107.  Some PTs and OTs have already assumed these advanced 
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roles in Canada and conduct clinics and provide treatments within and beyond their 
tradition roles108.  Continuing professional development has been associated with 
increasing PTs roles in the management of RA and OA125. 
There are programs that exist in Canada designed to offer specialty and advanced-
practice options to healthcare professionals in clinical practice.  Some of the current 
avenues for advanced-practice clinical education include facility-based training (i.e. 
Sunnybrook Holland Centre in Toronto), post-professional masters degrees (i.e. McMaster 
University (for PT and OT), Dalhousie University (for PT and OT), and The University of 
Western Ontario (for PT)), and certificate programs (i.e. Advanced Clinician Practitioner in 
Arthritis Care at St Michael’s and Sickkids Hospital in Toronto and The Arthritis 
Continuing Education (ACE) Program in British Columbia)125, 126.  There are also arthritis-
specific training opportunities available through The Arthritis Society127.    
When approved by their provincial professional regulators, PTs and OTs are 
allowed to perform certain tasks beyond their regular scope of practice.  For example, in 
Alberta, PTs and OTs are allowed to perform “advanced authorized activities” such as 
ordering imaging (i.e. x-rays, diagnostic ultrasound, magnetic resonance imaging) when 
appropriate128, 129.   
Rehabilitation professionals are an essential part of the interdisciplinary team for the 
management of persons with arthritis.  As PTs and OTs expand their scope of practice in 
advanced-practice roles, they may help to improve wait times, decrease costs, increase 
patient satisfaction, improve patient outcomes and optimize care for persons with arthritis.  
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7.5 Clinical Implications 
This study has shown that there are delays to rheumatology and rehabilitation 
services in Quebec.  The clinical implications of these findings are described in this section.  
 
Arthritis is one of the most common chronic health conditions in Canada and a 
major cause of morbidity, disability and health care utilization130-132.  We used patient 
scenarios to obtain appointments.  Unlike surveys that question clinicians about their 
impressions regarding wait times, we were able to document the current wait times for an 
appointment for persons with RA or OA in Quebec.   
There are many steps within the care trajectories that can contribute to wait times 
and therefore improvements can be made at various levels.  The wait time to see a 
rheumatologist may be the most amenable to improvement since rheumatologists strongly 
advocate for the need to see persons with RA as soon as possible7 and there are clear 
guidelines to begin appropriate pharmacological treatment5, 26-28.  
Efforts have been underway to sensitize primary care providers to referring patients 
with RA early on in the course of disease.  Rheumatologists want to see these patients as 
early as possible and specified referrals indicating suspicion of inflammatory arthritis may 
be helpful towards triaging these referrals.  The implementation of programs and 
prioritization tools to facilitate timely access is needed.  
 There is an increased focus on reducing wait times in Canada and policy makers 
and clinicians are seeking ways to improve their practice and the way services are 
delivered.  There is emerging evidence that the novel role of healthcare professionals as 
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advanced-practice clinicians may help reduce wait times and optimize care for patients.   
Utilizing PTs and OTs to their full scope can provide benefits for persons with RA and OA 
throughout the continuum of care.  Increased health promotion for the prevention of disease 
progression and the management of RA and OA, along with the integration of advanced-
practice models and public health programs will improve health outcomes and reduce the 
economical burden of arthritis on Quebecers.  
 
7.6 Limitations 
As mentioned in the manuscripts, there are several limitations to this study.  When 
trying to get an appointment, we were unable to provide the personal details required by 
some offices, which could have expedited the initial consultation and provided us with 
more accurate wait times for each scenario.  As previously mentioned, in those cases, an 
estimated wait time for the appointment date from the receptionist verbally was 
documented.  Also, this study is focused in the province of Quebec and results and may not 
be generalizable to the rest of Canada.  Common practice in Quebec is that the referring 
doctor gives the referral letter to the patient and it is then the patient’s responsibility to 
coordinate the appointment with the specialist.  This practice is not standard throughout the 
country. 
Specifically for the rheumatology component, we were unable to account for the 
additional time that might have been required to organize the information requested, resend 
the referral, and receive a response from the rheumatology office.  Moreover, had the 
primary care provider spoken directly to the rheumatologist to discuss the case or had the 
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patient called the office again offering to take the place of a cancellation, it could have also 
affected the wait times.  Nonetheless, our data suggest that more than half of the offices do 
not use any formal triage for new patients and that 32% were not accepting new patients.  
Additionally, regarding the rehabilitation component, this study does not account 
for the wait time differences between PT and OT as wait times were calculated as the time 
between the initial request and the appointment date received by one of the rehabilitation 
professionals, i.e. PT or OT.  Although the OA case falls more likely under the scope of 
practice of PTs and the RA case under the scope of practice of OTs, these patients could 
have benefited from the expertise of both professionals.  Even though they tend to have a 
different type of clientele, this study did not differentiate between rehabilitation centres and 
the other types of centres as they are all publicly funded and accessible PT and OT service 
providers.  
 
7.7 Future Research 
It is urgent that patients with arthritis receive prompt care and advice to manage 
their disease and prevent joint destruction and disability.  Future research strategies are 
needed to try and improve the situation.  These may include increasing awareness, 
implementing formal triage systems, expanding the role of allied health professionals, and 
having direct electronic linkages or networks for referral from the primary care provider’s 
office.   
A possible strategy to decrease the wait time to rheumatologists may be to establish 
a standardized model of triage or guidelines to ensure that referrals are completed and 
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appointments are obtained in a prompt fashion.  This is being piloted in more than one 
centre in Quebec103 and has been shown to decrease wait times in Alberta81.  Establishing a 
prioritization or prognostic tool, could be further explored in the province of Quebec to 
ensure equity of distribution between the low and high priority patients.      
A similar tool could be developed for rehabilitation services to optimize care and 
ensure the provision of appointments in a timely manner.  Since persons with arthritis are 
not always receiving prompt rehabilitation services, the implementation of a management 
program to decrease the impact of arthritis while waiting for services could be extremely 
useful for this population.  Further investigation is needed with regards to the evaluation 
appointment provided by some centres as it could serve as a stepping-stone to educate, raise 
awareness and introduce self-management programs to patients.  There is also a need for 
the implementation and exploration of the advanced-practice PT and OT roles in Quebec 
which may have the ability to fill the care gap while waiting for services or even reduce the 
wait time by appropriately managing and triaging patients.   
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Chapter 8: Conclusion 
 
Arthritis is the leading cause of pain and disability in Canada and a major public 
health challenge.  Persons with arthritis should have timely access to services in order to 
begin appropriate treatment and optimize health outcomes.  This is especially crucial in the 
case of rheumatoid arthritis where early treatment with appropriate medications is needed.  
However, prompt treatment for osteoarthritis and rehabilitation strategies for both types of 
arthritis may serve to prevent deformity and disability.   
The conclusions of our study are as follows.  Although RA is prioritized over OA 
when obtaining an appointment to a rheumatologist in the province of Quebec, there are 
still problems with access to a rheumatologist once referred.  The majority of persons with 
RA are still not receiving an appointment to a rheumatologist in a timely manner.  
Most persons with arthritis living in the province of Quebec are not receiving 
publicly available PT or OT intervention in a timely manner.  Those who require these 
services will either have to wait or access private services (i.e. pay for it themselves, or 
have supplementary insurance coverage).   
 Better methods for triage and increased resource allocation are needed to insure 
timely access to rheumatology and rehabilitation services that will ultimately optimize 
patient function and participation.  There is emerging evidence that the advanced role of the 
rehabilitation professional may help to improve wait times and optimize care for persons 
with arthritis.  Future research should focus on these new strategies in order to ensure 
timely and equitable care to persons with arthritis. 
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